FILE PHOTO: Moderna Therapeutics seen during COVID-19 in Massachusetts
ZURICH (Reuters) – Switzerland has signed an agreement with Moderna to secure early access to the COVID-19 vaccine the U.S. biotech company is developing, the government said on Friday.
Switzerland will get 4.5 million doses of the vaccine, enough to vaccinate 2.25 million people if as expected two doses are needed per patient.
The government is also talking to other vaccine companies and has allocated 300 million Swiss francs ($329 million) to the project.
($1 = 0.9116 Swiss francs)
(Reporting by John Revill; editing by John Stonestreet)
